“…The provirus MLV-(MOA) was assembled from a XbaI͞SpeI fragment from pHIT110 (14) containing a Moloney-murine sarcoma virus (MSV) 5Ј LTR with the U3 region replaced by the cytomegalovirus (CMV) immediate early promoter͞enhancer unit, a SpeI͞SalI fragment from p63-2 (15) with gag and the 5Ј part of the pol gene, a SalI͞NheI fragment with the 3Ј portion of the pol gene and the amphotropic env gene from pAMS (2), and a PCR-generated NheI͞EcoRI fragment with the MLV 3Ј LTR of p63-2. In plasmid pMLV-(MOA)⌬E the 3Ј LTR of pMLV-(MOA) was replaced with the 3Ј LTR from pMLV͞CRB⌬Mo (15). We have used the murine fibroblast line NIH͞3T3, the human fibrosarcoma line HT-1080 (ATCC CCL121), the human breast carcinoma-derived lines MCF-7 and MDA-MB-435S (supplied by Deutsches Krebsforschungszentrum Tumor Bank, Heidelberg), human B lymphoma lines Ramos and MHH-PREB-1 (German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany), and the human kidney line 293.…”